يعرض 1 - 10 نتائج من 73 نتيجة بحث عن '"Tawbi H. A."', وقت الاستعلام: 1.85s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

    المؤلفون: Andrews M. C., Duong C. P. M., Gopalakrishnan V., Iebba V., Chen W. -S., Derosa L., Khan M. A. W., Cogdill A. P., White M. G., Wong M. C., Ferrere G., Fluckiger A., Roberti M. P., Opolon P., Alou M. T., Yonekura S., Roh W., Spencer C. N., Curbelo I. F., Vence L., Reuben A., Johnson S., Arora R., Morad G., Lastrapes M., Baruch E. N., Little L., Gumbs C., Cooper Z. A., Prieto P. A., Wani K., Lazar A. J., Tetzlaff M. T., Hudgens C. W., Callahan M. K., Adamow M., Postow M. A., Ariyan C. E., Gaudreau P. -O., Nezi L., Raoult D., Mihalcioiu C., Elkrief A., Pezo R. C., Haydu L. E., Simon J. M., Tawbi H. A., McQuade J., Hwu P., Hwu W. -J., Amaria R. N., Burton E. M., Woodman S. E., Watowich S., Diab A., Patel S. P., Glitza I. C., Wong M. K., Zhao L., Zhang J., Ajami N. J., Petrosino J., Jenq R. R., Davies M. A., Gershenwald J. E., Futreal P. A., Sharma P., Allison J. P., Routy B., Zitvogel L., Wargo J. A.

    المساهمون: Andrews, M. C., Duong, C. P. M., Gopalakrishnan, V., Iebba, V., Chen, W. -S., Derosa, L., Khan, M. A. W., Cogdill, A. P., White, M. G., Wong, M. C., Ferrere, G., Fluckiger, A., Roberti, M. P., Opolon, P., Alou, M. T., Yonekura, S., Roh, W., Spencer, C. N., Curbelo, I. F., Vence, L., Reuben, A., Johnson, S., Arora, R., Morad, G., Lastrapes, M., Baruch, E. N., Little, L., Gumbs, C., Cooper, Z. A., Prieto, P. A., Wani, K., Lazar, A. J., Tetzlaff, M. T., Hudgens, C. W., Callahan, M. K., Adamow, M., Postow, M. A., Ariyan, C. E., Gaudreau, P. -O., Nezi, L., Raoult, D., Mihalcioiu, C., Elkrief, A., Pezo, R. C., Haydu, L. E., Simon, J. M., Tawbi, H. A., Mcquade, J., Hwu, P., Hwu, W. -J., Amaria, R. N., Burton, E. M., Woodman, S. E., Watowich, S., Diab, A., Patel, S. P., Glitza, I. C., Wong, M. K., Zhao, L., Zhang, J., Ajami, N. J., Petrosino, J., Jenq, R. R., Davies, M. A., Gershenwald, J. E., Futreal, P. A., Sharma, P., Allison, J. P., Routy, B., Zitvogel, L., Wargo, J. A.

    مصطلحات موضوعية: Animal, CTLA-4 Antigen, Cell Line, Tumor, Female, Human, Interleukin-1beta, Melanoma, Mice, Inbred C57BL, Programmed Cell Death 1 Receptor, Gastrointestinal Microbiome

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34239137; info:eu-repo/semantics/altIdentifier/wos/WOS:000672339400003; volume:27; issue:8; firstpage:1432; lastpage:1441; numberofpages:10; journal:NATURE MEDICINE; http://hdl.handle.net/11368/3007821Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85109895475; https://www.nature.com/articles/s41591-021-01406-6Test

    الإتاحة: https://doi.org/10.1038/s41591-021-01406-6Test
    http://hdl.handle.net/11368/3007821Test
    https://www.nature.com/articles/s41591-021-01406-6Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

    المؤلفون: Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., Cogdill, A. P., Zhao, L., Hudgens, C. W., Hutchinson, D. S., Manzo, T., de Macedo, M. Petaccia, Cotechini, T., Kumar, T., Chen, W. S., Reddy, S. M., Sloane, R. Szczepaniak, Galloway-Pena, J., Jiang, H., Chen, P. L., Shpall, E. J., Rezvani, K., Alousi, A. M., Chemaly, R. F., Shelburne, S., Vence, L. M., Okhuysen, P. C., Jensen, V. B., Swennes, A. G., McAllister, F., Sanchez, E. Marcelo Riquelme, Zhang, Y., Le Chatelier, E., Zitvogel, L., Pons, N., Austin-Breneman, J. L., Haydu, L. E., Burton, E. M., Gardner, J. M., Sirmans, E., Hu, J., Lazar, A. J., Tsujikawa, T., Diab, A., Tawbi, H., Glitza, I. C., Hwu, W. J., Patel, S. P., Woodman, S. E., Amaria, R. N., Davies, M. A., Gershenwald, J. E., Hwu, P., Lee, J. E., Zhang, J., Coussens, L. M., Cooper, Z. A., Futreal, P. A., Daniel, C. R., Ajami, N. J., Petrosino, J. F., Tetzlaff, M. T., Sharma, P., Allison, J. P., Jenq, R. R., Wargo, J. A.

    المصدر: Science, 2018 Jan 01. 359(6371), 97-103.

    الوصول الحر: https://www.jstor.org/stable/26401214Test


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022

    المؤلفون: Ascierto P. A., Blank C., Eggermont A. M., Garbe C., Gershenwald J. E., Hamid O., Hauschild A., Luke J. J., Mehnert J. M., Sosman J. A., Tawbi H. A., Mandala' M., Testori A., Caraco C., Osman I., Puzanov I.

    المساهمون: Ascierto, P. A., Blank, C., Eggermont, A. M., Garbe, C., Gershenwald, J. E., Hamid, O., Hauschild, A., Luke, J. J., Mehnert, J. M., Sosman, J. A., Tawbi, H. A., Mandala', M., Testori, A., Caraco, C., Osman, I., Puzanov, I.

    مصطلحات موضوعية: Adjuvant, Anti-PD-1, Immunotherapy, Melanoma, Neoadjuvant, Surgery, Targeted therapy

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37072748; info:eu-repo/semantics/altIdentifier/wos/WOS:000970128900001; volume:21; issue:1; firstpage:265; journal:JOURNAL OF TRANSLATIONAL MEDICINE; https://hdl.handle.net/11391/1566827Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85152863702

    الإتاحة: https://doi.org/10.1186/s12967-023-04100-yTest
    https://hdl.handle.net/11391/1566827Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Neoadjuvant immunotherapy for melanoma is now ready for clinical practice

    المؤلفون: Garbe C., Dummer R., Amaral T., Amaria R. N., Ascierto P. A., Burton E. M., Dreno B., Eggermont A. M. M., Hauschild A., Hoeller C., Kaufmann R., Lebbe C., Mandala' M., Menzies A. M., Moreno D., Michielin O., Nathan P., Patel S. P., Robert C., Schadendorf D., Lorigan P. C., Scolyer R. A., Tawbi H. A., van de Wiel B. A., Blank C., Long G. V.

    المساهمون: Garbe, C., Dummer, R., Amaral, T., Amaria, R. N., Ascierto, P. A., Burton, E. M., Dreno, B., Eggermont, A. M. M., Hauschild, A., Hoeller, C., Kaufmann, R., Lebbe, C., Mandala', M., Menzies, A. M., Moreno, D., Michielin, O., Nathan, P., Patel, S. P., Robert, C., Schadendorf, D., Lorigan, P. C., Scolyer, R. A., Tawbi, H. A., van de Wiel, B. A., Blank, C., Long, G. V.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37193799; info:eu-repo/semantics/altIdentifier/wos/WOS:000988452900001; volume:29; issue:6; firstpage:1310; lastpage:1312; numberofpages:3; journal:NATURE MEDICINE; https://hdl.handle.net/11391/1566843Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85159427261

    الإتاحة: https://doi.org/10.1038/s41591-023-02336-1Test
    https://hdl.handle.net/11391/1566843Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    ESMO consensus conference recommendations on the management of locoregional melanoma:under the auspices of the ESMO Guidelines Committee

    المؤلفون: Michielin, O., van Akkooi, A., Lorigan, P., Ascierto, P. A., Dummer, R., Robert, C., Arance, A., Blank, C. U., Chiarion Sileni, V., Donia, M., Faries, M. B., Gaudy-Marqueste, C., Gogas, H., Grob, J. J., Guckenberger, M., Haanen, J., Hayes, A. J., Hoeller, C., Lebbé, C., Lugowska, I., Mandalà, M., Márquez-Rodas, I., Nathan, P., Neyns, B., Olofsson Bagge, R., Puig, S., Rutkowski, P., Schilling, B., Sondak, V. K., Tawbi, H., Testori, A., Keilholz, U.

    المصدر: Michielin , O , van Akkooi , A , Lorigan , P , Ascierto , P A , Dummer , R , Robert , C , Arance , A , Blank , C U , Chiarion Sileni , V , Donia , M , Faries , M B , Gaudy-Marqueste , C , Gogas , H , Grob , J J , Guckenberger , M , Haanen , J , Hayes , A J , Hoeller , C , Lebbé , C , Lugowska , I , Mandalà , M , Márquez-Rodas , I , Nathan , P , ....

    مصطلحات موضوعية: adjuvant, consensus, immunotherapy, melanoma, targeted therapy, treatment

    الإتاحة: https://doi.org/10.1016/j.annonc.2020.07.005Test
    https://curis.ku.dk/portal/da/publications/esmo-consensus-conference-recommendations-on-the-management-of-locoregional-melanomaTest(ac865da6-1251-45ae-928f-0e1e4f0ea54a).html

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    ESMO consensus conference recommendations on the management of metastatic melanoma:under the auspices of the ESMO Guidelines Committee

    المؤلفون: Keilholz, U., Ascierto, P. A., Dummer, R., Robert, C., Lorigan, P., van Akkooi, A., Arance, A., Blank, C. U., Chiarion Sileni, V., Donia, M., Faries, M. B., Gaudy-Marqueste, C., Gogas, H., Grob, J. J., Guckenberger, M., Haanen, J., Hayes, A. J., Hoeller, C., Lebbé, C., Lugowska, I., Mandalà, M., Márquez-Rodas, I., Nathan, P., Neyns, B., Olofsson Bagge, R., Puig, S., Rutkowski, P., Schilling, B., Sondak, V. K., Tawbi, H., Testori, A., Michielin, O.

    المصدر: Keilholz , U , Ascierto , P A , Dummer , R , Robert , C , Lorigan , P , van Akkooi , A , Arance , A , Blank , C U , Chiarion Sileni , V , Donia , M , Faries , M B , Gaudy-Marqueste , C , Gogas , H , Grob , J J , Guckenberger , M , Haanen , J , Hayes , A J , Hoeller , C , Lebbé , C , Lugowska , I , Mandalà , M , Márquez-Rodas , I , Nathan , P , ....

    مصطلحات موضوعية: consensus, immunotherapy, melanoma, metastatic, targeted therapy, treatment

    الإتاحة: https://doi.org/10.1016/j.annonc.2020.07.004Test
    https://curis.ku.dk/portal/da/publications/esmo-consensus-conference-recommendations-on-the-management-of-metastatic-melanomaTest(ab050f52-2874-44a2-8b0a-b53852886b5d).html

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma

    المؤلفون: Dummer R., Long G. V., Robert C., Tawbi H. A., Flaherty K. T., Ascierto P. A., Nathan P. D., Rutkowski P., Leonov O., Dutriaux C., Mandala' M., Lorigan P., Ferrucci P. F., Grob J. J., Meyer N., Gogas H., Stroyakovskiy D., Arance A., Brase J. C., Green S., Haas T., Masood A., Gasal E., Ribas A., Schadendorf D.

    المساهمون: Dummer, R., Long, G. V., Robert, C., Tawbi, H. A., Flaherty, K. T., Ascierto, P. A., Nathan, P. D., Rutkowski, P., Leonov, O., Dutriaux, C., Mandala', M., Lorigan, P., Ferrucci, P. F., Grob, J. J., Meyer, N., Gogas, H., Stroyakovskiy, D., Arance, A., Brase, J. C., Green, S., Haas, T., Masood, A., Gasal, E., Ribas, A., Schadendorf, D.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35030011; info:eu-repo/semantics/altIdentifier/wos/WOS:000799683000006; volume:40; issue:13; firstpage:1428; lastpage:1438; numberofpages:11; journal:JOURNAL OF CLINICAL ONCOLOGY; https://hdl.handle.net/11391/1566855Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85128751763

    الإتاحة: https://doi.org/10.1200/JCO.21.01601Test
    https://hdl.handle.net/11391/1566855Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    مؤتمر
    Dabrafenib (D) and trametinib (T) plus spartalizumab (S) in patients (pts) with previously untreated BRAF V600-mutant unresectable or metastatic melanoma: Three-year overall survival (OS) data from the randomized part 3 of the phase III COMBI-i trial

    المؤلفون: Dummer, R., Long, G. V., Tawbi, H. A., Flaherty, K., Ascierto, P. A., Nathan, P. D., Rutkowski, P., Leonov, O., Mandala, M., Lorigan, Paul C, Ferrucci, P. F., Grob, J. J., Meyer, N., Gogas, H., Stroyakovskiy, D., Arance, A. M., Pakhle, N., Waters, S., Ribas, A., Schadendorf, D.

    المساهمون: Universitäts Spital Zürich, Zurich, Switzerland

    العلاقة: https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.9527Test; Dummer R, Long GV, Tawbi HA, Flaherty K, Ascierto PA, Nathan PD, et al. Dabrafenib (D) and trametinib (T) plus spartalizumab (S) in patients (pts) with previously untreated BRAF V600-mutant unresectable or metastatic melanoma: Three-year overall survival (OS) data from the randomized part 3 of the phase III COMBI-i trial. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680302346.; http://hdl.handle.net/10541/625822Test; Journal of Clinical Oncology

    الإتاحة: https://doi.org/10.1200/JCO.2022.40.16_suppl.9527Test
    http://hdl.handle.net/10541/625822Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Advances in the systemic treatment of melanoma brain metastases

    المؤلفون: Glitza Oliva, I.C., Schvartsman, G., Tawbi, H.

    المساهمون: Novartis Pharmaceuticals Corporation

    المصدر: Annals of Oncology ; volume 29, issue 7, page 1509-1520 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdy185Test
    https://api.elsevier.com/content/article/PII:S0923753419321143?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419321143?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)

    المؤلفون: Glitza, I.C., Rohlfs, M.L., Iqbal, M., Richard, J., Burton, E., Duncan, S., Brown, C., Anderson, J., Hwu, P., Hwu, W.-J., Wong, M., Yee, C., Patel, S., Woodman, S., Amaria, R., Diab, A., Tawbi, H., Davies, M.

    المصدر: Annals of Oncology ; volume 29, page viii464 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1093/annonc/mdy289.057Test
    https://api.elsevier.com/content/article/PII:S0923753419497561?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753419497561?httpAccept=text/plainTest
    http://academic.oup.com/annonc/article-pdf/29/suppl_8/mdy289.057/26139580/mdy289.057.pdfTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث